News & Events

2016, Press Releases, Scientific

Philogen S.p.A. announced that Pfizer Inc. (NYSE: PFE) has exercised options granted under the agreement established in December 2014

Jan 21, 2016

Philogen S.p.A. announced that Pfizer Inc. (NYSE: PFE) has exercised options granted under the agreement established in December 2014 for the potential development and commercialization of multiple antibody drug conjugates (ADCs). Siena, Italy, 21st January 2016.

PRESS RELEASE PHILOGEN PFIZER ADC OPTION EXERCISE

Last News & Events

Oct 2024 1

Philogen is pleased to invite you to a new webinar on October 1, 2024, at 15:00 GMT | 16:00 CET.

Oct 2024 1

Sun Pharma e Philogen stipulano un accordo di commercializzazione, licenza e fornitura in esclusiva per la commercializzazione del prodotto innovativo FIBROMUN a livello mondiale.